New Jersey Pharmaceutical Company
Outcome
OIG enforcement action against New Jersey Pharmaceutical Company for healthcare fraud. Penalty: $12.6 million.
Details
New Jersey Pharmaceutical Company — OIG Enforcement (2015)
OIG took enforcement action against New Jersey Pharmaceutical Company in NJ in 2015 involving healthcare fraud violations in the Independent Pharmacies sector.
Penalty: $12.6 million
Violation types: Healthcare Fraud
Entity type: Pharmacy
Penalty type: Settlement
Location: NJ
Source: New Jersey Pharmaceutical Company Settles Case Involving Misrepresenting Drug Pricing Data to Medicare
How Crucible Prevents This
Crucible's compliance monitoring controls for Independent Pharmacies would have detected the patterns underlying this violation through automated screening, documentation enforcement, and real-time alert escalation.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works